eversyn
Glycobiology tools
eversyn GmbH is a biotechnology company spun off from the Max Planck Institute Magdeburg. Their mission is to leverage cutting-edge biotechnology to make glycobiology tools, such as glyco-enzymes and nucleotide sugars, more accessible. This will help scientists to unlock groundbreaking discoveries and drive innovations in nutrition and biopharma.
Mission
- Affordability: they offer cost-efficient, high-quality activated sugars and enzymes tailored for your R&D needs.
- Made in Germany: Leveraging precision engineering and scientific excellence, all their products are developed locally.
- Expert Support: their team provides unparalleled expertise in glycoengineering, ensuring customized solutions for your applications.
Expertise
Activated sugars are essential intermediates in biochemical processes, often used in glycosylation reactions. These sugars, such as UDP-glucose or GDP-mannose, are "activated" by enzymes, enabling them to participate in the formation of glycosidic bonds. Enzymes specific to these sugars are critical tools in research for synthesizing glycoconjugates, studying carbohydrate metabolism, and developing therapeutics.
eversyn's technology allows the production of activated sugars for affordable prices. They can synthesize activated sugars from inexpensive substrates using highly efficient multi-enzyme cascades. Their goal is to make them available for diverse applications in food and pharma. eversyn's cell-free synthesis process is robust and scalable.
Biogenex
Molecular pathology systems
GenomeMe
IHC monoclonal antibodies
RayBiotech
Proteomic discovery tools
BBI Solutions
Diagnostic raw materials
Hillgene
Innovative products for cell and gene therapy